Page last updated: 2024-09-02

anecortave acetate and Neovascularization, Optic Disc

anecortave acetate has been researched along with Neovascularization, Optic Disc in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murakami, T; Nukada, M; Ogino, K; Unoki, N; Yoshimura, N1
Joussen, AM; Kirchhof, B1
Eandi, CM; Freund, KB; Klais, CM; Ober, MD; Sadeghi, SN; Slakter, JS; Sorenson, JA; Spaide, RF; Yannuzzi, LA1
Eandi, CM; Freund, KB; Klais, CM; Ober, MD; Slakter, JS; Sorenson, JA; Yannuzzi, LA1
Arnold, J; Hunyor, A; Karacorlu, M; Kelly, S; Wilson, D1
Clark, AF; Collier, RJ; Penn, JS; Rajaratnam, VS1

Trials

2 trial(s) available for anecortave acetate and Neovascularization, Optic Disc

ArticleYear
Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:7

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiomatosis; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Intraocular Pressure; Macular Degeneration; Male; Pilot Projects; Pregnadienediols; Prospective Studies; Retinal Neovascularization; Retinal Vessels; Tomography, Optical Coherence; Visual Acuity

2006
Anecortave acetate for the treatment of idiopathic perifoveal telangiectasia: a pilot study.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:7

    Topics: Adult; Aged; Angiogenesis Inhibitors; Capillary Permeability; Female; Fluorescein Angiography; Fovea Centralis; Humans; Male; Middle Aged; Pilot Projects; Pregnadienediols; Prospective Studies; Retinal Neovascularization; Retinal Vessels; Telangiectasis; Treatment Outcome; Visual Acuity

2006

Other Studies

4 other study(ies) available for anecortave acetate and Neovascularization, Optic Disc

ArticleYear
Time-lapse imaging of retinal angiogenesis reveals decreased development and progression of neovascular sprouting by anecortave desacetate.
    Investigative ophthalmology & visual science, 2010, Volume: 51, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Chemokine CXCL12; Diagnostic Imaging; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Mice; Mice, Inbred C57BL; Microscopy, Electron; Organ Culture Techniques; Pregnadienediols; Retinal Neovascularization; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2010
[Angiogenesis in ophthalmology. A theme with a future].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:4

    Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Choroidal Neovascularization; Corneal Neovascularization; Diabetic Retinopathy; Endothelial Growth Factors; Eye Diseases; Humans; Infant, Newborn; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Degeneration; Metalloendopeptidases; Neovascularization, Pathologic; Organic Chemicals; Platelet-Derived Growth Factor; Pregnadienediols; Retinal Neovascularization; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003
Diagnostic and therapeutic challenges.
    Retina (Philadelphia, Pa.), 2007, Volume: 27, Issue:8

    Topics: Adult; Angiogenesis Inhibitors; Combined Modality Therapy; Epiretinal Membrane; Female; Fluorescein Angiography; Hemangioblastoma; Humans; Laser Coagulation; Macular Edema; Neoplasm Recurrence, Local; Pregnadienediols; Retinal Neoplasms; Retinal Neovascularization; Vision Disorders; Visual Acuity; von Hippel-Lindau Disease

2007
The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.
    Investigative ophthalmology & visual science, 2001, Volume: 42, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Blotting, Northern; Disease Models, Animal; Female; Humans; Infant, Newborn; Injections; Male; Nuclease Protection Assays; Plasminogen Activator Inhibitor 1; Pregnadienediols; Random Allocation; Rats; Rats, Sprague-Dawley; Retinal Neovascularization; Retinopathy of Prematurity; RNA Probes; RNA, Messenger; Vitreous Body

2001